CLEAR adds LabCorp COVID-19 test results to ﾓHealth Passﾔ mobile app
On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…
CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments
On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…
Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillan
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
LabCorp COVID-19 molecular test innovation received FDA authorization
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
FDA approved drug combination for treating mesothelioma
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
National Science Foundation announced investment of $40 million in future of US manufacturing
On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….
Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabﾙ
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabﾙ in critical…
UConn funded five COVID-19 research projects, announced additional funding
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
Veklury (remdesivir) made available directly from distributor
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugﾒs distributor. Veklury is an…
Gilead Sciences updated supply and distribution of Vekluryﾮ (remdesivir) in the US
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
NIH assessed and expanded COVID-19 testing for underserved communities
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
Oxford researchers started new trial on the use of anti-TNF to treat Covid-19 in care homes
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
National Science Foundation funded more than 80 startups to address COVID-19 challenges
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
NIH funded first nationwide network to study rare forms of diabetes
On Sept. 30, 2020, the NIH announced funding of a nationwide study to discover the cause of several…
WHO welcomed nearly $1 billion in pledges to bolster access to tests, treatments and vaccines to end COVID-19
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
BioNTech and Pfizer announced Nature publication of German phase 1/2 study data from mRNA-based vaccine candidate against SARS-CoV-2
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
Windtree announced FDA acceptance of IND application for phase 2 clinical trial studying KL4 Surfactant in acute lung injury in adults with COVID-19
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
CureVac Initiated phase 2a clinical trial of COVID-19 vaccine candidate
On Sept. 29, 2020, CureVac announced that the first participant has been dosed in a Phase 2a clinical…
Increased COVID-19 cases reported in US among adults aged 18ﾖ22 years
On Sept. 29, 2020, the CDC reported that during Aug. 2ﾖSept. 5, 2020, weekly COVID-19 cases among persons…
Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the NIH announed that researchers had designed ﾓminiproteinsﾔ that bound tightly to the SARS-CoV-2…
Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countries
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
Eiger announced results of investigator sponsored study in outpatients with mild and uncomplicated COVID-19
On Sept. 28, 2020, Eiger BioPharmaceuticals announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in…
DOD and HHS awarded $20 million contract to On Demand Pharmaceuticals to develop critical pharmaceutical ingredients
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million…
ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trials
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
NIH-funded study shed light on abnormal neural function in rare genetic disorder
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…